SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
608.00    8.00 (1.33%)
Bid:
607.00
Ask:
610.00
Spread: 3.00 (0.494%)
Market Cap: £735.73m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Oxford Biomedica News

Qualye Munro director buys 3.3 per cent stake ahead of de-listing
16 Jul 2013

Qualye Munro director buys 3.3 per cent stake ahead of de-listing

Glen Lewy, a Non-Executive Director of corporate financial advisory firm Qualye Munro bought a big stake in the company ahead of its proposed de-listi...

Signet CFO sells amid share-price strength
20 Jun 2013

Signet CFO sells amid share-price strength

Signet Jewelers, the largest speciality retail jewellery in the US and UK, saw its Chief Financial Officer (CFO) offload part of his stake this week f...

Oxford Instruments lifts annual profit
11 Jun 2013

Oxford Instruments lifts annual profit

Oxford Instruments, which provides high-tech tools and systems for industry and research, recorded improved adjusted pre-tax profit for the year as it...

Oxford Biomedica Chief Scientific Officer steps down
6 Jun 2013

Oxford Biomedica Chief Scientific Officer steps down

Gene-based biopharmaceutical company Oxford BioMedica confirmed that Dr Stuart Naylor will step down as Chief Scientific Officer at its Annual General...

STOCKS NEWS EUROPE-UK small caps drop 0.5 percent
3 Jun 2013

STOCKS NEWS EUROPE-UK small caps drop 0.5 percent

UK small caps fall 0.5 percent, underperforming both the midcaps, off 0.3 percent, and the FTSE AIM All Share index, 0.2 percent firmer. Gene-based bi...

Oxford Biomedica slumps as clinical trial is put on hold
3 Jun 2013

Oxford Biomedica slumps as clinical trial is put on hold

Shares of gene-based biopharmaceutical company Oxford Biomedica fell sharply after it confirmed clinical trials of its eye products have been put on h...

Monday broker round-up UPDATE
3 Jun 2013

Monday broker round-up UPDATE

Anglo Pacific Group: Finncap cuts target price from 320p to 279p staying with its buy recommendation. Ashtead Group: Citi takes target price from 660...

Oxford BioMedica pauses some trials after finding potential impurities
3 Jun 2013

Oxford BioMedica pauses some trials after finding potential impurities

June 3 (Reuters) - Gene-based biopharmaceutical company Oxford BioMedica said it put some of its trials on hold, after the company detected very low c...